Back to search

Sweden· SE-19990924000348

Atacand Plus 16 mg/12,5 mg Tablett

A medicinal product containing hydrochlorothiazide + candesartan cilexetil, registered in Sweden by Cheplapharm Arzneimittel GmbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedAtacand Plus 16 mg/12,5 mg TablettATC—REGISTER NO.SE-19990924000348PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Hydrochlorothiazide + Candesartan Cilexetil
Manufacturer
Cheplapharm Arzneimittel GmbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    19990924000348

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hydrochlorothiazide + candesartan cilexetil in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydrochlorothiazide + candesartan cilexetil products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Atacand Plus, Atacand Plus Mite
  • Belgium · Atacand Plus, Candesartan Plus Hct Eg
  • Bulgaria · Кандесартан Hct Актавис, Кандестар Н
  • Cyprus · Atacand Plus, Candepress Comp
  • Czechia · Cancombino, Carzap Hct
  • Germany · Atacand Plus, Atacand Plus Forte
  • Denmark · Atacand Zid, Candemox Comp
  • Estonia · Atacand Plus, Canocombi
  • Spain · Atacand Plus, Atacand Plus Forte
  • Finland · Atacand Plus, Candemox Comp
  • France · Candesartan/Hydrochlorothiazide Arrow, Candesartan/Hydrochlorothiazide Arrow Lab
  • United Kingdom (Northern Ireland) · Candesartan And Hydrochlorothiazide, Candesartan/Hydrochlorothiazide
  • Greece · Atacand Plus, Fyronexe Plus®
  • Croatia · Karbicombi
  • Hungary · Karbicombi
  • Ireland · Atacand Plus, Blopress Plus
  • Iceland · Candesartan Hct Beta, Candpress Comp
  • Italy · Blopresid, Candesartan E Idroclorotiazide Alter
  • Lithuania · Candesartan Hct Actavis, Canocombi
  • Luxembourg · Atacand Plus, Candesartan Comp Ratiopharm
  • Latvia · Canocombi, Carzan Hct
  • Malta · Candesartan/Hydrochlorothiazide Aurobindo Pharma (Malta)
  • Netherlands · Atacand Plus, Candesartan Cilexetil Hctz Krka
  • Norway · Atacand Plus, Atacand Plus Mite
  • Poland · Candepres Hct, Carzap Hct
  • Portugal · Blopress, Candesartan + Hidroclorotiazida Alter
  • Romania · Candesartan Hct Swyssi, Candesartan Hidroclorotiazidă Aurobindo
  • Slovenia · Atacand Plus, Candea Hct
  • Slovakia · Atacand Plus, Candesartan Hct Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/75024df7-42ba-47e2-8777-cd8d32dfeddd
GET /v1/drugs/75024df7-42ba-47e2-8777-cd8d32dfeddd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "19990924000348",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19990924000348",
  "product_doc_link": "https://docetp.mpa.se/LMF/Atacand%20Plus%20tablet%20ENG%20SmPC_09001bee807a37a3.pdf"
}

See everything about hydrochlorothiazide + candesartan cilexetil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.